Divi's Laboratories Q2 FY27: PAT ₹902 Cr & Rev ₹3,144 Cr

Metric	Value
Revenue	₹3,144 Cr
Net Profit (PAT)	₹902 Cr

📢 Key Event
Divi's Laboratories reports Q1 FY27 results with 10% constant currency revenue growth and ₹902 crores PAT

🔄 What Changed
10% YoY revenue growth; ₹902 crores PAT; 70% capex completion; 80-85% unit utilization; ₹2,000 crores estimated capex

🔮 What's Next
Double-digit revenue growth projected for full year; validation batches to contribute similarly to Q1; margin pressure to be managed via pricing

💡 Investor Takeaway
Shareholders should note margin pressure from raw material inflation is being addressed through pricing, with double-digit growth expected despite quarterly volatility.

Divi's Laboratories reported consolidated revenue of ₹3,144 crores and profit after tax of ₹902 crores for Q1 FY27, up 10% in constant currency YoY. Export revenue contributed 90% of standalone sales, with custom synthesis driving 60% of revenue. The company highlighted margin pressure from raw material inflation but implemented price increases to offset it, projecting double-digit full-year growth despite quarterly lumpiness. Capex on three major projects reached 70% completion with an estimated ₹2,000 crores investment. Unit utilization stands at 80-85%, and inventory was increased by 3 months to ensure supply continuity amid geopolitical risks.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How will 3-month inventory impact Q2 gross margins?" "What is the timeline for commercializing Brivaracetam?" "When will the new Capex projects reach full capacity?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 6 August 2026

CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SUMEETINDS Sumeet Industries Limited Financial Results VISAKAIND Visaka Industries Limited Corporate Action VISAKAIND Visaka Industries Limited Corporate Action SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results VSTL Vibhor Steel Tubes Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.